Skip to main content
. 2023 Jul 18;110(8):1394–1413. doi: 10.1016/j.ajhg.2023.06.013

Table 1.

Summary of DHX9 variant alleles

Individual(s) Phenotype Position (hg19) Nucleotide and protein De novo Allele count and frequency (gnomAD) CADD score REVEL score Conservation (phylop100way)
1 NDD chr1: 182822498G>A c.422G>A (p.Arg141Gln) yes absent 22.3 0.20 6.67
2 (BAB15412) NDD chr1: 182845191T>G c.1822T>G (p.Cys608Gly) yes absent 24.3 0.31 7.24
3 and 12 NDD chr1: 182856253G>C c.3497G>C (p.Arg1166Pro) yes absent 23.8 0.67 6.74
4 NDD chr1: 182825663A>AA c.627−4dupA (p.?) yes absent
5 NDD chr1: 182835663G>A c.1417G>A (p.Val473Ile) yes 1 htz; 1 in 141,456 26.3 0.34 9.14
6 NDD chr1: 182856244A>G c.3488A>G (p.Lys1163Arg) yes absent 22.0 0.27 6.17
7 NDD chr1: 182850561G>T c.2786+1G>T (p.?) unknown absent 35.0 9.05
8 NDD chr1: 182827250C>T c.685C>T (p.Arg229Ter) yes absent 38 4.29
9 NDD chr1: 182829219G>A c.1232G>A (p.Gly411Glu) yes absent 25.1 0.73 9.09
10 NDD chr1: 182845626CGA>C c.2075_2076delGA (p.Glu693GlyfsTer7) yes absent
11 NDD chr1: 182847239G>A c.2282G>A (p.Arg761Gln) yes absent 32 0.90 7.33
13 NDD chr1: 182847238C>T c.2281C>T (p.Arg761Trp) yes absent 29 0.91 2.36
14 NDD chr1: 182856543C>T c.3787C>T (p.Gln1263Ter) unknown absent 37 0.83
Iossifov et al.19,a NDD chr1: 182852665G>A c.3155G>A (p.Arg1052Gln) yes absent 27.2 0.21 9.10
BAB4646a NDD chr1: 182827238G>A c.674−1G>A (p.?) unknown absent 35 8.95
M42-1a NDD chr1: 182847247C>T c.2290C>T (p.Arg764Ter) unknown absent 36 1.75
15 (BAB12399) CMT chr1: 182849656A>G c.2537A>G (p.Asp846Gly) yes absent 26.7 0.21 6.84
16 (BAB14692) CMT chr1: 182848543G>C c.2510G>C (p.Arg837Thr) unknown absent 31 0.15 5.39
17 (BAB704) CMT chr1: 182856519G>A c.3763G>A (p.Ala1255Thr) unknown absent 16.19 0.14 2.18

Abbreviations: NDD, neurodevelopmental disorder; CMT, Charcot-Marie-Tooth disease; CADD, Combined Annotation Dependent Depletion; gnomAD, Genome Aggregation Database; htz, heterozygote; REVEL, Rare Exome Variant Ensemble Learner.

a

Limited clinical details are available, or there is evidence that multilocus pathogenic variation contributes to a blended phenotype. See the supplemental notes for additional details.